Patents by Inventor Ami MIZUGAKI

Ami MIZUGAKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10898456
    Abstract: Ingesting an agent containing cystine or a salt thereof, as an active ingredient, is effective for improving exercise-induced gastrointestinal disorder, providing an improvement effect equal to or better than that by the conventional technology on exercise-induced gastrointestinal disorders including exercise-induced decline in gastrointestinal tract barrier function.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: January 26, 2021
    Assignee: AJINOMOTO CO., INC.
    Inventors: Yoshihito Nogusa, Ami Mizugaki
  • Publication number: 20190247350
    Abstract: Compositions which contain at least one of cystine and glutamine as an active ingredient are useful for improving decreased absorption in the gastrointestinal tract or promoting absorption in the gastrointestinal tract.
    Type: Application
    Filed: April 25, 2019
    Publication date: August 15, 2019
    Applicant: AJINOMOTO CO., INC.
    Inventors: Ami MIZUGAKI, Sakiko TOYODA, Yoshihito NOGUSA
  • Publication number: 20190070139
    Abstract: Ingestion or administration of cysteine is effective for improving physical capacity for activity and provides a superior improving effect as compared to conventional compositions for the enhancement of improvement of physical capacity for activity relating to physical functions.
    Type: Application
    Filed: September 13, 2018
    Publication date: March 7, 2019
    Applicant: AJINOMOTO CO., INC.
    Inventors: Yoshihito NOGUSA, Ami MIZUGAKI
  • Publication number: 20180098954
    Abstract: Ingesting an agent containing cystine or a salt thereof, as an active ingredient, is effective for improving exercise-induced gastrointestinal disorder, providing an improvement effect equal to or better than that by the conventional technology on exercise-induced gastrointestinal disorders including exercise-induced decline in gastrointestinal tract barrier function.
    Type: Application
    Filed: December 8, 2017
    Publication date: April 12, 2018
    Applicant: AJINOMOTO CO., INC.
    Inventors: Yoshihito NOGUSA, Ami MIZUGAKI